Applied Therapeutics Inc (NASDAQ:APLT) currently has a daily average trading volume of 5.66M but it saw 15230075 shares traded in last market. With a market cap of 84.42M USD, the company’s current market price of $0.73 came falling about -9.54 while comparing to the previous closing price of $0.80. In past 52 weeks, the stock remained buoying in the range of price level as high as $10.62 and as low as $0.77. In the recent trading on the day, stock has struck highest price mark of $0.6866 while lowest mark touched by it was $0.8196.
Taking a look at 20-day trading activity of Applied Therapeutics Inc (APLT) gives us an average price of $0.9672, while its current price level is -93.17% below from 52-week high level whereas it is -6.10% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $4.8750 while that of 200 days or SMA-200 reads an average of $5.5389. A closer look into the stock’s movement over the week reveals that its volatility is standing at 13.85% during that period while stretching the period over a month that decreases to 12.69%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 19.02 which implies that the stock is in oversold territory.
UBS downgraded its recommendation for the stock as a “Neutral” from “Buy” on December 02, 2024 while assigning a price target range of $13-$2. RBC Capital Mkts also issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $12 and $4.
Over the week, APLT’s stock price is moving -15.27% down while it is -43.32% when we observe its performance for the past one month. Year-to-date it is -15.27% down and over the past year, the stock is showing a downside performance of -67.90%.
Currently, Applied Therapeutics Inc’s total number of outstanding shares is 116.36M. Stock’s beta reads 1.92. Stock has a price to book (P/B) ratio of 14.33.
